New Scientific Director strengthens Heidelberg Engineering product development

Charles Reimann
Charles Reisman, newly appointed Scientific Director at Heidelberg Engineering.

Heidelberg, Germany – Charles Reisman has joined Heidelberg Engineering’s global management team as Scientific Director. In this newly created role, he will be responsible for the clinical research plan that directly feeds into the product development pipeline.

Heidelberg Engineering is strengthening its Clinical Research team with the addition of Charles Reisman as Scientific Director. Charles is an accomplished clinical validation expert with decades of ophthalmic industry and other high-technology expertise. He holds an Electrical Engineering degree from the Massachusetts Institute of Technology (MIT) and several patents on signal and image processing methodologies within the field of ophthalmic imaging. He has published in numerous distinguished peer-reviewed scientific journals and book chapters and is also well versed in deep learning and artificial intelligence.

In his new position, Charles will focus on the strategic leadership of Heidelberg Engineering’s clinical research and trial efforts, ultimately geared towards executing the company’s product development pipeline. For that purpose, he will not only work closely with the Research and Development, Clinical and Regulatory Affairs teams but primarily with external researchers from across the world.

“I look forward to contributing to Heidelberg Engineering’s product development goals within our heavily regulated environment. I am particularly inspired by the collaborations with leading clinicians and researchers across the world as well as the impressive team of R&D experts at Heidelberg Engineering, that are among the brightest in the industry,” said Charles Reisman, newly appointed Scientific Director.

“Charles brings excellent credentials and a deep understanding of the ophthalmic research and development landscape. We are confident that his expertise will help us bring more and even better products to the market. We are specifically focused on early detection of diseases by supporting the confident identification of clinical biomarkers,” said Arianna Schoess Vargas, Managing Director of Heidelberg Engineering.

From its inception in 1990, Heidelberg Engineering has collaborated with scientists, clinicians and industry to develop innovative products that deliver clinically relevant benefits. With the appointment of Charles Reisman as Scientific Director, the company signals a renewed commitment to this guiding principle.

back to overview